Vascular Biogenics Ltd. | Ownership
Companies that own Vascular Biogenics Ltd.
Empery Asset Management LP
1,904,762
5.31%
1,109,170
3.86%
06/25/2018
Heights Capital Management, Inc.
1,896,902
5.29%
1,896,902
0.09%
06/30/2018
Sabby Capital LLC
1,856,169
5.18%
1,856,169
1.53%
06/30/2018
Knoll Capital Management LP
896,771
2.5%
0
1.31%
06/30/2018
683 Capital Management LLC
346,574
0.97%
-53,426
0.07%
06/30/2018
Macquarie Investment Management Business Trust
200,000
0.56%
0
0%
06/30/2018
Raymond James & Associates, Inc. (Invt Mgmt)
82,142
0.23%
0
0%
06/30/2018
Société Générale Gestion SA
43,100
0.12%
43,100
0%
06/30/2018
Virtu Financial BD LLC
37,807
0.11%
-30,415
0%
06/30/2018
Spark Investment Management LLC
29,300
0.08%
29,300
0%
06/30/2018
| Address |
8 HaSatat Street
Modi'in JM 7178106
Israel
|
|
Employees
|
- |
| Website |
http://www.vblrx.com |
| Updated |
07/08/2019 |
| Vascular Biogenics Ltd. is in the clinical-stage biopharmaceutical company, which engages in the discovery, development and commercialization of first-in-class treatments for cancer. It offers different programs for cancer and inflammatory disease patients such as vascular targeting system and Lecinoxoids. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel. |
